Overview
Description
Takeda Pharmaceutical Company Limited is a global pharmaceutical corporation rooted in the research and development, manufacturing, and sale of medical products and vaccines. Its primary function lies in advancing health and enhancing lives through innovative medicines across various domains, including oncology, gastroenterology, neuroscience, and rare diseases. Takeda stands as a leading force particularly in the biologics space, where it develops advanced therapies to treat complex diseases. Operating in over 80 countries, the company leverages a rich heritage that spans over two centuries, emphasizing patient-centric healthcare solutions. With its headquarters in Japan, Takeda is renowned for integrating cutting-edge science and technology with expansive market knowledge, striving to address critical healthcare needs. In the financial market, Takeda Pharmaceutical holds substantial significance as one of the largest pharma companies in the world, reflecting its impact on both healthcare advancements and global stock exchanges. Its varied portfolio not only boosts investor confidence but also underscores its role in fostering sustainable health outcomes worldwide.
About
CEO
Mr. Christophe Weber
Employees
49281
Address
1-1, Nihonbashi-Honcho 2-chome
Chuo-ku
Tokyo, 103-8668
Chuo-ku
Tokyo, 103-8668
Phone
81 3 3278-2111
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Germany
MIC code
XSTU